biologic

Trulicity

dulaglutide

Loss of exclusivitySeptember 2032projected — 12-year biologic exclusivity estimate
CompanyEli Lilly and Company

Drug detail

Brand nameTrulicity
Active ingredientdulaglutide
Strength4.5MG/0.5ML
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
FDA approvalSeptember 2020
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Not found